Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJJ6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,203
Award facts
- Contract value 100% obligated
- $13,203.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,203.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of BOTOX 200 Unit Vials. This firm fixed-price delivery order, issued on December 30, 2025, with an ultimate completion date of January 22, 2026, carries no set-aside designation, indicating the award was made through full and open competition. The delivery order falls under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical pharmaceutical supplier within the federal military medical supply chain, evidenced by its recent award of a single-award IDC under PPV-G GEN V on November 13, 2025, with a $499,999,999 ceiling value extending through December 31, 2036. The company's product portfolio encompasses branded and generic pharmaceuticals, biologics, vaccines, and specialty medical consumables, with delivery orders ranging from under $100 to exceeding $115,000. This BOTOX delivery order exemplifies the company's role in fulfilling specialized pharmaceutical requirements for military healthcare operations, leveraging its small business status to compete effectively in federal procurement while maintaining consistent performance across multiple therapeutic categories.
Quick answers
Who was awarded contract SPE2DR26FDJJ6?
SPE2DR26FDJJ6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26FDJJ6 worth?
The government has obligated $13,203 on SPE2DR26FDJJ6.
Is contract SPE2DR26FDJJ6 an order under another contract?
Yes. SPE2DR26FDJJ6 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJJ6 competed?
The extent of competition for SPE2DR26FDJJ6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award